L Montus Kid Tablet is a combination medication containing Levocetirizine 2.5 mg and Montelukast 4 mg, formulated specifically for pediatric use to manage allergic conditions. Levocetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, effectively reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic rhinitis and urticaria. Montelukast is a leukotriene receptor antagonist that blocks the action of leukotrienes, inflammatory mediators responsible for bronchoconstriction, mucus production, and airway edema, thereby providing relief in conditions like asthma and allergic rhinitis. The synergistic action of these two agents offers comprehensive control of both upper and lower respiratory allergic manifestations. L Montus Kid Tablet is indicated for the treatment of seasonal and perennial allergic rhinitis, chronic urticaria, and as an adjunct in the management of asthma in children. It is generally well-tolerated, with a low incidence of sedation compared to first-generation antihistamines. Dosage should be administered as prescribed by a healthcare professional, considering the child’s age and weight. Caution is advised in patients with hepatic or renal impairment. This combination enhances compliance by reducing the pill burden and targeting multiple pathways involved in allergic inflammation.